Intervenção Fisioterapêutica na Atrofia Muscular Espinhal: revisão de literatura
DOI:
https://doi.org/10.34024/rnc.2021.v29.11029Palavras-chave:
AME, fisioterapia, doenças neuromuscularesResumo
Introdução. A atrofia muscular espinhal (AME) é uma doença neuromuscular degenerativa de caráter progressiva. Há diversas abordagens terapêuticas para que se minimize as progressões advindas da doença. O prognóstico favorável é altamente dependente tanto do diagnóstico precoce, quanto do início prematuro do tratamento medicamentoso e de todas as intervenções, dentre elas, a fisioterapia. A intervenção fisioterapêutica pode proporcionar maior sobrevida e com maior qualidade de vida aos pacientes. Objetivos. Analisar, por meio de uma revisão bibliográfica, quais foram as intervenções fisioterapêuticas aplicadas na atrofia muscular espinhal nos últimos 10 anos. Método. Revisão bibliográfica de artigos publicados nas bases de dados Biblioteca Virtual em Saúde (BVS), Scielo, Pubmed, LILACS, e Physiotherapy Evidence Database (PEDro). Resultados. Dos 162 artigos encontrados, apenas 6 artigos cumpriram todos os critérios de inclusão. Foram encontradas formas de avaliação e de recursos fisioterapêuticos utilizados para o tratamento da AME. Conclusões. Diante da pesquisa, verificou-se que as principais intervenções fisioterapêuticas utilizadas na AME nos últimos 10 anos foram exercícios em plataformas vibratórias, exercícios de fortalecimento com resistência, exercícios aquáticos e exercícios respiratórios.
Downloads
Métricas
Referências
Parente V, Corti S. Advances in spinal muscular atrophy therapeutics. Ther Adv Neurol Disord 2018;11:1-13. https://doi.org/10.1177/1756285618754501
Faravelli I, Nizzardo M, Comi GP, Corti S. Spinal muscular atrophy — recent therapeutic advances for an old challenge. Nat Ver Neurol 2015; 11:351-9. https://doi.org/10.1038/nrneurol.2015.77
Kolb SJ, Kissel JT. Spinal Muscular Atrophy. Neurol Clin 2015;33:831-46. https://doi.org/10.1016/j.ncl.2015.07.004
Finkel RS, McDermott MP, Kaufmann P, Darras BT, Chung WK, Sproule DM, et al. Observational study of spinal muscular atrophy type I and implications for clinical trials. Neurology 2014;83:810-7. https://doi.org/10.1212/WNL.0000000000000741
Ministério da Saúde (endereço na internet). Parecer Referencial n. 00016/2017/CONJUR¬MS/CGU/AGU. Manifestação Jurídica referencial sobre o medicamento Spinraza®-Nusinersen (acessado em 2020). Disponível em: http://portalarquivos.saude.gov.br/images/pdf/2017/maio/30/000016-2017--Spinraza-Nusinersen.pdf
Ruhno C, McGovern VL, Avenarius MR, Snyder PJ, Prior TW, Nery FC, et al. Complete sequencing of the SMN2 gene in SMA patients detects SMN gene deletion junctions and variants in SMN2 that modify the SMA phenotype. Hum Genet 2019;138:241-56.
https://doi.org/10.1007/s00439-019-01983-0
Cao Y-Y, Zhang W-H, Qu Y-J, Bai J-L, Jin Y-W, Wang H; et al. Diagnosis of Spinal Muscular Atrophy: A Simple Method for Quantifying the Relative Amount of Survival Motor Neuron Gene 1/2 Using Sanger DNA Sequencing. Chin Med J 2018;131:2921-9.
https://doi.org/10.4103/0366-6999.247198
Riessland M. Is there hope for spinal muscular atrophy synthetic pharmacotherapy? Expert Opin Pharmacother 2019;20:1-4. https://doi.org/10.1080/14656566.2019.1595585
Pechmann A, König K, Bernert G, Schachtrup K, Schara U, Schorling D, et al. SMArtCARE - A platform to collect real-life outcome data of patients with spinal muscular atrophy. Orphanet J Rare Dis 2019;14:18. https://doi.org/10.1186/s13023-019-0998-4
Kades MGP, Aquino MES, Laurindo Souza LP. Síndrome de Werdnig-Hoffman: Aspectos Patológicos e os Saberes da Enfermagem. Recien 2019;7:40-7. https://doi.org/10.24276/rrecien2358-3088.2017.7.20.40-47
Stark C, Duran I, Cirak S, Hamacher S, Hoyer-Kuhn H-K, Semler O, et al. Vibration-Assisted Home Training Program for Children With Spinal Muscular Atrophy. Child Neurol Open 2018;5:1-9. https://doi.org/10.1177/2329048X18780477
Lewelt A, Krosschell KJ, Stoddard GJ, Weng C, Xue M, Marcus RL, et al. Resistance strength training exercise in children with spinal muscular atrophy. Muscle Nerve 2015;52:559-67.
https://doi.org/10.1002/mus.24568
Marques TBC, Neves JC, Portes LA, Salge JM, Zanoteli E, Reed UC. Air stacking: effects on pulmonary function in patients with spinal muscular atrophy and in patients with congenital muscular dystrophy. J Bras Pneumol 2014;40:528-34. https://doi.org/10.1590/s1806-37132014000500009
Vry J, Schubert IJ, Semler O, Haug V, Schonau E, Kirschner J. Whole-body vibration training in children with Duchenne muscular dystrophy and spinal muscular atrophy. Eur J Paediatr Neurol 2014;18:140-9. https://doi.org/10.1016/j.ejpn.2013.09.005
Salem Y, Gropack SJ. Aquatic Therapy for a Child with Type III Spinal Muscular Atrophy: A Case Report. Acta Fisiotr 2010;23:102-6. https://doi.org/10.3109/01942638.2010.493097
Nygren-Bonnier M, Markström A, Lindholm P, Mattsson E, Klefbeck B. Glossopharyngeal pistoning for lung insufflation in children with spinal muscular atrophy type II. Acta Paediatr 2009;98:1324-8. https://doi.org/10.1111/j.1651-2227.2009.01343.x
Koul R, Al-Futaisi A, Al-Thihli K, Bruwer Z, Scott P. Segmental Spinal Muscular Atrophy Localised to the Lower Limbs: First case from Oman. Sultan Qaboos Univ Med J 2017; e355-7.
https://doi.org/10.18295/squmj.2017.17.03.018
Chung BH, Wong VC, Ip P. Spinal muscular atrophy: survival pattern and functional status. Pediatrics 2004;114:e548-53.
https://doi.org/10.1542/peds.2004-0668
Febrer A, Rodriguez N, Alias L, Tizzano E. Measurement of muscle strength with a handheld dynamometer in patients with chronic spinal muscular atrophy. J Rehabil Med 2010;42:228-31.
https://doi.org/10.2340/16501977-0507
Merlini L, Bertini E, Minetti C, Mongini T, Morandi L, Angelini C, et al. Motor function-muscle strength relationship in spinal muscular atrophy. Muscle Nerve 2004;29:548-52.
https://doi.org/10.1002/mus.20018
Noto Y-i, Misawa S, Mori M, Kawaguchi N, Kanai K, Shibuya K, et al. Prominent fatigue in spinal muscular atrophy and spinal and bulbar muscular atrophy: evidence of activity-dependent conduction block. Clin Neurophysiol 2013;124:1893-8.
https://doi.org/10.1016/j.clinph.2012.12.053
Alexanderson H, Dastmalchi M, Esbjörnsson-Liljedahl M, Opava CH, Lundberg IE. Benefits of intensive resistence training in patients with chronic polyomyosits or dermatomyosits. Arthritis Rheum 2007;57:768-77. https://doi.org/10.1002/art.22780
Monazzam MR, Shoja E, Zakerian SA, Foroushani AR, Shoja M, Gharaee M, et al. Combined effect of whole-body vibration and ambient lighting on human discomfort, heart rate, and reaction time. Int Arch Occup Environ Health 2018;91:537-45.
https://doi.org/10.1007/s00420-018-1301-z
Alam MM, Khan AA, Farooq M. Effect of whole-body vibration on neuromuscular performance: A literature review. Work 2018;59:571-83. https://doi.org/10.3233/WOR-182699
Zanoteli E, Maximino JR, Reed UC, Chadi G. Spinal muscular atrophy: from animal model to clinical trial. Funct Neurol 2010;25:73-9.
Montagnese F, Thiele S, Wenninger S, Schoser B. Long-term whole-body vibration training in two late-onset Pompe disease patients. Neurol Sci 2016;37:1357-60. https://doi.org/10.1007/s10072-016-2612-z
Fitzgerald DA, Doumit M, Abel F. Changing respiratory expectations with the new disease trajectory of nusinersen treated spinal muscular atrophy [SMA] type 1. Paediatr Respir Rev 2018;28:11-7.
https://doi.org/10.1016/j.prrv.2018.07.002
Torres-Castro R, Vilaró J, Vera-Uribe R, Vasconcello L, Puppo H. Acute Effects of Air Stacking Versus Glossopharyngeal Breathing in Patients with Neuromuscular Disease. BJMMR 2016,14:1-8. https://doi.org/10.9734/BJMMR/2016/23192
Stehling F, Bouikidis A, Schara U, Mellies U. Mechanical insufflation/exsufflation improves vital capacity in neuromuscular disorders. Chron Respir Dis 2015;12:31-5.
https://doi.org/10.1177/1479972314562209
Israel VL, Pardo MBL. Hydrotherapy: application of an Aquatic Functional Assessment Scale (AFAS) in aquatic motor skills learning. Am Int J Contemp Res 2014;4:42-52.
https://core.ac.uk/download/pdf/197151851.pdf
da Silva KM, Braga D, Hengels RC, Beas ARV, Rocco FM. The impact of aquatic therapy on the agility of a non-ambulatory patient with Duchenne Muscular Dystrophy. Acta Fisiátrica 2012;19:42-5. https://doi.org/10.5935/0104-7795.20120009 32.Bottura AP, Accacio LMP, Mazzitelli C. Effects of a kinesiotherapy and aquatic physiotherapy program onto the neuropsycomotor development. Fisioterap Pesq 2006;13:67-75. https://doi.org/10.1590/fpusp.v13i3.76315
Mercuri E, Darras BT, Chiriboga CA, Day JW, Campbell C, Connolly AM, et al. Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy. N Engl J Med 2018;378:625-35. https://doi.org/10.1056/NEJMoa1710504
Simoens S, Huys I. Market access of Spinraza (Nusinersen) for spinal muscular atrophy: intellectual property rights, pricing, value and coverage considerations. Gene Ther 2017;24:539-41.
https://doi.org/10.1038/gt.2017.79
Glascock J, Lenz M, Hobby K, Jarecki J. Cure SMA and our patient community celebrate the first approved drug for SMA. Gene Ther 2017;24:498-500. https://doi.org/10.1038/gt.2017.39
De Oliveira CM. Estudo da qualidade de vida em crianças e adolescentes com Atrofia Muscular Espinhal (Tese). Rio de Janeiro: Universidade Federal do Rio de Janeiro, 2010. https://www.livrosgratis.com.br/ler-livro-online-109876/estudo-da-qualidade-de-vida-em-criancas-e-adolescentes-com-atrofia-muscular-espinhal
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2021 Francielly Suzaine da Silva, Júlia Manoela Prada Rodrigues , Rômulo Nolasco de Brito , Thaisa Cardoso Macedo , Andrea Delfino Borgmann
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Aceito: 2021-04-27
Publicado: 2021-06-17
Português
English
Español
